Macquarie Asset Management’s private equity fund is understood to have sealed the deal to acquire a 100% stake in Korean contract development and manufacturing organisation (CDMO) Genuone Sciences from local investor IMM Private Equity, according to sources familiar with the matter.
Start your deal-making journey now!
Subscribe now to enjoy unlimited access at just $59.
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Already a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com
